Rhythm Pharmaceuticals, Inc.
RYTMNASDAQHealthcare● Active
$85.93
$-0.48(-0.55%)
Market Cap$5.9B
P/E Ratio—
52W High$122.2
52W Low$60.7
Rhythm Pharmaceuticals, Inc. (RYTM) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RYTM · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.39B | $0.32B | $0.28B | $0.33B | $0.29B |
| Net Receivables | $0.03B | $0.02B | $0.01B | $0.01B | $0.00B |
| Inventory | $0.03B | $0.02B | $0.01B | $0.00B | $0.00B |
| Total Current Assets | $0.47B | $0.37B | $0.31B | $0.35B | $0.31B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Total Assets | $0.48B | $0.39B | $0.33B | $0.38B | $0.33B |
| Liabilities | |||||
| Short-Term Debt | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.01B | $0.00B | $0.00B | $0.01B |
| Total Current Liabilities | $0.11B | $0.12B | $0.06B | $0.04B | $0.04B |
| Long-Term Debt | $0.24B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.34B | $0.23B | $0.16B | $0.12B | $0.05B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.35B) | ($1.16B) | ($0.89B) | ($0.71B) | ($0.53B) |
| Total Stockholders Equity | $0.14B | $0.16B | $0.17B | $0.26B | $0.28B |
| Total Liab & Equity(computed) | $0.48B | $0.39B | $0.33B | $0.38B | $0.33B |
| Debt Summary | |||||
| Total Debt | $0.25B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Debt | $0.19B | ($0.09B) | ($0.06B) | ($0.13B) | ($0.06B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Rhythm Pharmaceuticals, Inc. data
About Rhythm Pharmaceuticals, Inc. (RYTM) Balance Sheet
Rhythm Pharmaceuticals, Inc. (RYTM) balance sheet shows total assets of $0.48B with cash of $0.39B. Total liabilities are $0.34B, total debt $0.25B, and stockholders equity $0.14B.
Frequently asked questions
RYTM · 4 questionsRhythm Pharmaceuticals, Inc. has total debt of $0.25B with net debt of $0.19B.
RYTM total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10